PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, providing promising progress across many clinical and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA supplies a safer, far more trustworthy alternative for therapeutic use,